Compounds > danazol
Page last updated: 2024-08-23

danazol and losartan potassium

danazol has been researched along with losartan potassium in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Ohno, A; Sugino, N; Tanaka, M1
al-Momen, AK; Gader, AM; Huraib, SO; Sulaimani, F1
Clausen, NT; Hasselbalch, HC; Jensen, BA1
Chung, H; Luketic, VA; Price, AS; Purrington, A; Sanyal, AJ; Shiffman, ML; Sterling, RK; Stravitz, RT1
Koduri, PR1
Hanson, CA; Huang, J; Li, CY; Mesa, RA; Pardanani, A; Tefferi, A; Wu, W1

Trials

1 trial(s) available for danazol and losartan potassium

ArticleYear
Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
    American journal of hematology, 2002, Volume: 70, Issue:2

    Topics: Aged; Aged, 80 and over; Anemia; Blood Transfusion; Danazol; Drug Therapy, Combination; Erythropoietin; Female; Hemoglobins; Humans; Interferon-alpha; Male; Middle Aged; Primary Myelofibrosis; Recombinant Proteins

2002

Other Studies

6 other study(ies) available for danazol and losartan potassium

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
[Drugs and other substances inducing hypertension].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50 Suppl

    Topics: Antidepressive Agents, Tricyclic; Contraceptives, Oral; Cyclosporine; Danazol; Erythropoietin; Extracellular Space; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Hypertension; Monoamine Oxidase Inhibitors; Recombinant Proteins; Sodium, Dietary

1992
Low dose danazol is effective in management of erythropoietin induced thrombosis.
    Thrombosis research, 1991, Dec-01, Volume: 64, Issue:5

    Topics: Adult; Danazol; Erythropoietin; Female; Humans; Kidney Failure, Chronic; Male; Plasminogen Inactivators; Recombinant Proteins; Thrombosis

1991
Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
    The American journal of gastroenterology, 2005, Volume: 100, Issue:6

    Topics: Antibodies; Danazol; Drug Hypersensitivity; Epoetin Alfa; Erythropoietin; Estrogen Antagonists; Follow-Up Studies; Hematinics; Hepatitis C, Chronic; Humans; Male; Middle Aged; Radioimmunoprecipitation Assay; Recombinant Proteins; Red-Cell Aplasia, Pure

2005
Refractory megaloblastic anemia in a patient with AIDS: Response to danazol.
    American journal of hematology, 2005, Volume: 80, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia, Megaloblastic; Danazol; Erythropoietin; Humans; Male; Recombinant Proteins

2005
Risk factors for leukemic transformation in patients with primary myelofibrosis.
    Cancer, 2008, Jun-15, Volume: 112, Issue:12

    Topics: Cell Transformation, Neoplastic; Danazol; Erythropoietin; Female; Humans; Leukemia; Male; Middle Aged; Primary Myelofibrosis; Risk Factors

2008